β-Thalassemia

Definition

Absence or reduced production of β-globin gene leading to anemia.

Signs & Symptoms

Severe anemia in major cases become apparent at 3 – 6 months of life. Hepatosplenomegaly, thalassemia facies and cortex bone thinning. Iron overload leafing to stunted growth, heart and renal failure, recurrent infections.

Risk Factors

Most prevalent monogenic disorders worldwide which is about 7% of the world population.

Causes

Mainly autosomal recessive inheritance. More than 200 mutations have been found on the β-globin gene. Decreased or absence of the β-globin gene causes precipitation of excess α-globin gene leading to ineffective erythropoiesis.

Peripheral blood characteristics

Severe hypochromic microcytic anemia with increased reticulocyte count, normoblasts and target cells.

Bone marrow characteristics

Severe hypochromic microcytic anemia with increased reticulocyte count, normoblasts and target cells.

Important investigations & related results

Hemoglobin electrophoresis shows absence or faint HbA with HbF as the predominant subtype. Similarly for HPLC.

Treatment & management

Regular blood transfusion, iron chelation therapy, vitamin C, splenectomy, endocrine therapy and bone marrow transplantation.

This is the text for the image

View our Upcoming Products

To facilitate the learning of our students we have developed a number of products that are due for release soon. These include a Practical Manual for Medical Undergraduates and two boardgames.